May 2013 FDA Recall Drug by Actavis South Atlantic Llc
D-829-2013 - Failed Impurity/Degradation Specification; "Related Compound C"

This Class II drug recall was voluntarily initiated by Actavis South Atlantic Llc on May 15, 2013 for the product Drug. The FDA reported the reason for recall as failed impurity/degradation specification; "related compound c". The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-829-2013

Reason for Recall
Failed Impurity/Degradation Specification; "Related Compound C"
Initiated
05-15-2013
Reported
08-07-2013
Quantity
A total of 133,968 bottles (units)

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Actavis South Atlantic LLC
Ranitidine Syrup (Ranitidine Oral Solution USP) 15 mg/mL, Rx Only. Manufactured by VistaPharm, Inc., Birmingham, AL 35242. Distributed by Actavis Mid Atlantic LLC 1877 Kawai Road, Lincolnton, NC 28092 USA

Batch or Lot Expiration Information

Lot# Lot Numbers: 247900, 251000, 256000, 261200, 263600, 266700, 277100, 280300 and 284300.